The recent media articles have been focusing on the govt review of the Prosthesis List which regulates the govt reimbursement levels for prosthetics. Private hospitals have been getting charged at higher levels than public which the govt wants to clamp down on. This affects the likes of LHC. However PGC doesn't sell regulated products.
I see the risks to PGC as more indirect. If the likes of Medibank squeeze the private hospitals they may push back on price increases etc from their suppliers ie PGC. Less overall fat in the system means less fat to share around
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $645.5M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.0¢ | 39.0¢ | $6.365K | 16.32K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 370887 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 48408 | 7 |
View Market Depth
| Last trade - 10.50am 29/07/2025 (20 minute delay) ? |
| PGC (ASX) Chart |